HIV integrase inhibitors in ART-experienced patients-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

HIV integrase inhibitors in ART-experienced patients

Published:2012-09 Issue:5 Volume:7 Page:415-421
ISSN:1746-630X
Container-title:Current Opinion in HIV and AIDS
language:en
Short-container-title:Current Opinion in HIV and AIDS

Author:

Blanco Jose-Luis,Martinez-Picado Javier

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Virology,Infectious Diseases,Oncology(nursing),Oncology,Hematology,Immunology

Reference27 articles.

1. Discovery of a small-molecule HIV-1 integrase inhibitor-binding site

2. Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial

3. Long-Term Efficacy and Safety of the HIV Integrase Inhibitor Raltegravir in Patients With Limited Treatment Options in a Phase II Study

4. Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dolutegravir and the management of HIV/AIDS in the South African adult population;SA Pharmaceutical Journal;2024-04

2. Dolutegravir-Based Regimen for Maintenance of Viral Suppression in People Living with HIV: 48-Week Results in Real-Life Setting;AIDS Research and Human Retroviruses;2021-06-01

3. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir-based and non-raltegravir-based combination antiretroviral therapy regimens;HIV Medicine;2017-10-06

4. A QSAR study of integrase strand transfer inhibitors based on a large set of pyrimidine, pyrimidone, and pyridopyrazine carboxamide derivatives;Journal of Molecular Structure;2017-08

5. Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study);Infectious Diseases;2017-07-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3